Shandong Lukang Pharmaceutical Co.,Ltd. (SHA:600789)
China flag China · Delayed Price · Currency is CNY
6.88
-0.13 (-1.85%)
Nov 13, 2026, 3:00 PM CST

SHA:600789 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
136.3112.3394.62246.17138.0189.1
Depreciation & Amortization
427.85429.43401.6381.13348.12307.46
Other Amortization
21.6920.110.411.441.882.25
Loss (Gain) From Sale of Assets
-0.17-0.17-153.42-0.28-2.83-0.16
Asset Writedown & Restructuring Costs
0.180.180.15-10.68
Loss (Gain) From Sale of Investments
5.295.297.567.26.533.18
Provision & Write-off of Bad Debts
5.165.162.520.988.4224.39
Other Operating Activities
-85.27109.89159.56142.19163.54113.83
Change in Accounts Receivable
169.33169.33-265.44-124.56-516.07-83.45
Change in Inventory
362.99191.09-145.067.62-314.68-356.13
Change in Accounts Payable
-331.3-331.3-7.36-53.29614.7778.61
Change in Other Net Operating Assets
-168.553.350.690.45--
Operating Cash Flow
527698.17402.82604.01444.38177.49
Operating Cash Flow Growth
73.33%73.32%-33.31%35.92%150.36%-24.33%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-365.88-338.86-279.18-337.91-428.36-488.57
Sale of Property, Plant & Equipment
28.39104.220.310.030.151.34
Divestitures
---2.13--
Investment in Securities
0.031.19---15.82-42.18
Other Investing Activities
----34.030.03-4.99
Investing Cash Flow
-337.46-233.47-258.87-369.78-444.01-534.4

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-1,8751,6762,1792,1452,577
Total Debt Issued
1,3491,8751,6762,1792,1452,577
Long-Term Debt Repaid
--1,839-1,814-2,198-1,973-2,144
Lease Payments
------0.84
Total Debt Repaid
-1,974-1,839-1,814-2,198-1,973-2,144
Net Debt Issued (Repaid)
-624.9335.98-137.41-18.57171.81432.68
Issuance of Common Stock
1,1871,18717.3661.8841.761.98
Common Dividends Paid
-106.89-166.3-233.49-143.73-139.59-166.39
Other Financing Activities
98.3299164.446.5-79.29-6.95
Financing Cash Flow
553.331,156-189.1-93.92-5.31261.32

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-142.2410.812.76.460.83
Net Cash Flow
728.861,622-34.34143.011.52-94.76

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
161.12359.31123.64266.0916.02-311.07
Free Cash Flow Growth
-190.62%-53.54%1561.36%--
Free Cash Flow Margin
2.80%6.23%1.98%4.33%0.29%-6.32%
Free Cash Flow Per Share
0.150.380.140.300.02-0.35
Levered Free Cash Flow
562.94452.7-278.32-59-39.51-436.35
Unlevered Free Cash Flow
573.27493.81-231.21-9.5121.77-395.64
Free Cash Flow After Leases
161.12359.31123.64266.0916.02-311.92

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
139.49154.41130.55231.1665.86104.04
Change in Working Capital
15.9715.97-410.17-174.83-220.3-363.25